GEM 21S (GROWTH-FACTOR ENHANCED MATRIX

Bone Grafting Material, Dental, With Biologic Component

FDA Premarket Approval P040013

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the gem 21s (growth-factor enhanced matrix). The device is indicated to treat the following periodontally related defects: 1) intrabony periodontal defects 2) furcation periodontal defects 3) gingival recession associated with periodontal defects.

DeviceGEM 21S (GROWTH-FACTOR ENHANCED MATRIX
Classification NameBone Grafting Material, Dental, With Biologic Component
Generic NameBone Grafting Material, Dental, With Biologic Component
ApplicantLynch Biologics LLC
Date Received2004-03-12
Decision Date2005-11-18
Notice Date2005-11-28
PMAP040013
SupplementS
Product CodeNPZ
Docket Number05M-0474
Advisory CommitteeDental
Expedited ReviewNo
Combination Product Yes
Applicant Address Lynch Biologics LLC 5526 Joseph Street franklin, TN 37064
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040013Original Filing
S025 2020-11-27 Real-time Process
S024 2020-04-17 Normal 180 Day Track No User Fee
S023 2020-03-24 Normal 180 Day Track No User Fee
S022 2019-03-21 Normal 180 Day Track No User Fee
S021 2015-06-22 Normal 180 Day Track No User Fee
S020 2015-01-21 Special (immediate Track)
S019 2014-05-05 135 Review Track For 30-day Notice
S018 2012-02-29 Special (immediate Track)
S017 2011-06-24 Normal 180 Day Track No User Fee
S016 2010-12-11 Normal 180 Day Track
S015 2009-08-14 Normal 180 Day Track No User Fee
S014 2009-07-06 Normal 180 Day Track No User Fee
S013 2008-03-26 Normal 180 Day Track
S012 2007-11-23 Normal 180 Day Track No User Fee
S011 2007-05-22 135 Review Track For 30-day Notice
S010
S009 2006-12-22 Special (immediate Track)
S008 2006-10-20 30-day Notice
S007
S006 2006-08-09 30-day Notice
S005 2006-07-31 Real-time Process
S004 2006-05-31 Normal 180 Day Track No User Fee
S003 2006-04-06 Normal 180 Day Track No User Fee
S002 2006-02-27 Real-time Process
S001

NIH GUDID Devices

Device IDPMASupp
00850001118002 P040013 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.